Ayurvedic Management Of Hepatitis B

Phase 2

Completed

• Conditions: Health Condition 1: K739- Chronic hepatitis, unspecified

• Registration Number: CTRI/2018/05/014023
• Lead Sponsor: Patanjali Ayurveda College

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2019-02-18
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

1. Patients irrespective of sex, religion, occupation and chronicity will be selected.

2. Patients with two times higher ALT levels than the upper limit of normal value will be selected.

3. Patients with symptoms and signs of hepatitis B, abnormal liver functions and diagnosed cases of Chronic Hepatitis B infection will be registered.

Exclusion Criteria

1. Patients aged >65 years or <18 years will be excluded.

2. Pregnant or lactating women will be excluded.

3. Patients who had hepatitis C or other hepatic viral infection, autoimmune hepatitis and drug-induced hepatitis or alcoholic hepatitis will be excluded.

4. Patients with severe complications of the cardiovascular, renal or hematopoietic systems and mental diseases will be excluded.

5. Patients will be excluded having decompensated liver disease.

6. Patients with prolonged or a history of ascites, developed hepato-cellular carcinoma, hepatic encephalopathy, variceal bleeding will be excluded.

7. Patients with a history of using IFN or antiviral agents or corticosteroids or immunosuppressive drugs will also be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
All investigations like SGOT, SGPT, HbsAg, Anti-Hbe, PCRTimepoint: before intervention- <br/ ><br>Each Follow up- After every 2 months

Secondary Outcome Measures

Name	Time	Method
All investigations like SGOT, SGPT, HbsAg, Anti-Hbe, PCRTimepoint: After trial of 6 months